Johnson & Johnson (JNJ): Price Target and June Short Interest Disclosure

Johnson & Johnson (JNJ) stock is expected to deviate a maximum of $10.19 from the average target price of $117.17 for the short term period. 12 Street Experts have initiated coverage on the stock with the most promising target being $125 and the most muted being $93.

Johnson & Johnson (JNJ) has witnessed a drop of 4.3% or 1,077,805 shares in its short figure. The short interest diminution took it from 25,204,503 on June 15,2016 to 24,126,698 on June 30,2016. In terms of floated shares, the short interest was calculated to be 0.9%. The days to cover are 3 given that the daily volume averaged 8,716,803 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 12th.

Also, Jefferies maintains its view on Johnson & Johnson (NYSE:JNJ) according to the research report released by the firm to its investors. The shares have now been rated Hold by the stock experts at the ratings house. Jefferies raises the price target from $108 per share to $109 per share on Johnson & Johnson. The rating by the firm was issued on June 14, 2016.


Johnson & Johnson (NYSE:JNJ): stock turned positive on Thursday. Though the stock opened at $122.98, the bulls momentum made the stock top out at $123.74 level for the day. The stock recorded a low of $122.91 and closed the trading day at $123.18, in the green by 0.15%. The total traded volume for the day was 5,322,718. The stock had closed at $123 in the previous days trading.

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Companys primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Companys subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Companys research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.